LNC:NYSELincoln National Corporation Analysis
Data as of 2026-05-19 - not real-time
$34.69
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Lincoln National appears dramatically undervalued – the discounted cash‑flow estimate suggests a price many multiples higher than the current market level, while the price‑to‑earnings multiple sits far below the industry average. The company also offers an attractive dividend yield that far exceeds typical peers, supported by a low payout ratio and a massive cash pile that dwarfs its debt burden. Revenue is growing at a solid pace and free cash flow is positive, providing a sturdy foundation for continued dividend payments.
On the technical side, the stock is hovering near a key support zone, the 20‑day moving average sits above price, and the MACD line is below its signal, signaling short‑term bearish pressure despite a neutral overall trend. RSI is in the middle range, suggesting no extreme momentum, while beta and recent volatility point to heightened sensitivity to market swings. Recent earnings commentary highlighted a streak of operating‑income growth and the declaration of a preferred‑stock dividend, reinforcing the narrative of steady cash generation.
On the technical side, the stock is hovering near a key support zone, the 20‑day moving average sits above price, and the MACD line is below its signal, signaling short‑term bearish pressure despite a neutral overall trend. RSI is in the middle range, suggesting no extreme momentum, while beta and recent volatility point to heightened sensitivity to market swings. Recent earnings commentary highlighted a streak of operating‑income growth and the declaration of a preferred‑stock dividend, reinforcing the narrative of steady cash generation.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price is near a technical support level
- MACD shows bearish divergence
- high dividend yield provides downside cushion
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- substantial valuation upside versus DCF estimate
- ongoing revenue growth and positive free cash flow
- sustainable dividend supported by strong cash position
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- consistent cash generation and low payout ratio
- strategic position in life‑insurance and annuity markets
- long‑term upside from undervaluation and sector stability
Key Metrics & Analysis
Financial Health
Revenue Growth12.50%
Profit Margin9.17%
P/E Ratio3.8
ROE18.77%
ROA0.28%
Debt/Equity65.73
P/B Ratio0.7
Op. Cash Flow$243.0M
Free Cash Flow$2.9B
Industry P/E16.7
Technical Analysis
TrendNeutral
RSI42.3
Support$34.06
Resistance$38.48
MA 20$36.28
MA 50$35.35
MA 200$39.54
MACDBearish
VolumeIncreasing
Fear & Greed Index89.61
Valuation
Fair Value$516.88
Target Price$42.83
Upside/Downside23.47%
GradeUndervalued
TypeBlend
Dividend Yield5.19%
Risk Assessment
Beta1.30
Volatility28.49%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.